Magnus Björsne is the Executive Director of AZ BioVentureHub, an innovation initiative at global pharmaceutical company AstraZeneca’s Gothenburg, Sweden campus that uses a novel approach to open innovation: it allows smaller biotechs and academic groups to work in close proximity to the skills and capabilities that reside within big pharma.
To read the article you must be a subscriber to The Innovator’s Radar.
If you are already a Radar subscriber click here to sign into your account. If you have trouble accessing your account click here.
For a free trial Radar Subscription click here.
